keyword
https://read.qxmd.com/read/38656630/safety-and-efficacy-of-multiple-dose-versus-single-dose-mibg-therapy-in-patients-with-refractory-pheochromocytoma-and-paraganglioma-a-single-center-retrospective-analysis
#1
JOURNAL ARTICLE
Naoto Wakabayashi, Shiro Watanabe, Takashige Abe, Junki Takenaka, Kenji Hirata, Rina Kimura, Keita Sakamoto, Nobuo Shinohara, Kohsuke Kudo
OBJECTIVE: To investigate the incidence of adverse events (AEs) following single and multiple administrations of I-131 metaiodobenzylguanidine (MIBG) therapy for inoperable pheochromocytomas and paragangliomas (PPGLs). METHODS: A single-center retrospective study was conducted on patients with inoperable PPGLs who underwent I-131 MIBG therapy between January 2000 and December 2020. A total of 28 patients with available electronic medical records were included. The treatment consisted of a single intravenous administration of 150 mCi (5...
April 24, 2024: Annals of Nuclear Medicine
https://read.qxmd.com/read/38655818/sars-cov-2-infection-induces-thymic-atrophy-mediated-by-ifn-%C3%AE-in-hace2-transgenic-mice
#2
JOURNAL ARTICLE
Zaigham Abbas Rizvi, Srikanth Sadhu, Jyotsna Dandotiya, Puja Sharma, Akshay Binayke, Virendra Singh, Vinayaka Das, Ritika Khatri, Rajesh Kumar, Sweety Samal, Manjula Kalia, Amit Awasthi
Pathogenic infections cause thymic atrophy, perturb thymic T-cell development, and alter immunological response. Previous studies reported dysregulated T-cell function and lymphopenia in coronavirus disease-19 (COVID-19). However, immunopathological changes in the thymus associated with severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection have not been elucidated. Here, we report that SARS-CoV-2 infects thymocytes, and induces CD4+ CD8+ (double positive; DP) T-cell apoptosis leading to thymic atrophy and loss of peripheral TCR repertoire in K18-hACE2 transgenic mice...
April 24, 2024: European Journal of Immunology
https://read.qxmd.com/read/38644606/late-onset-lymphopenia-during-radiation-is-associated-with-an-increased-risk-of-tumor-recurrence-in-newly-diagnosed-pediatric-medulloblastoma
#3
JOURNAL ARTICLE
Holly B Lindsay, Michael E Scheurer, Anthony K Allam, Bryony J Lucas, Susan L McGovern, Murali Chintagumpala, Arnold C Paulino
BACKGROUND: Recent data found a correlation between lymphopenia occurring early during craniospinal radiation therapy (RT) and risk of disease recurrence in newly diagnosed childhood medulloblastoma. However, the population included patients who received chemotherapy prior to or during RT. Here, we investigate the effect of lymphopenia during RT in patients with newly diagnosed pediatric medulloblastoma who were chemotherapy-naïve. PROCEDURE: We analyzed 79 patients with newly diagnosed medulloblastoma (ages 2-21 years) treated between 1997 and 2013 with craniospinal RT...
April 21, 2024: Pediatric Blood & Cancer
https://read.qxmd.com/read/38641993/intrahepatic-mucinous-cholangiocarcinoma-with-recurrent-colic-in-a-horse-case-report-and-literature-review-of-cholangiocarcinoma-in-horses
#4
JOURNAL ARTICLE
Daniel Felipe Barrantes Murillo, Russell C Cattley, John M Cullen, Cornelius Withers, Jordan Towns, Rachel Pfeifle, Anne Wooldridge, Rachel L A L T Neto
A 17-y-old Arabian mare was presented to the Auburn Large Animal Veterinary Teaching Hospital with a long-term history of intermittent mild recurrent colic that responded to medical treatment. CBC revealed mild lymphopenia; serum biochemistry findings were of increased gamma-glutamyl transferase and creatine kinase activities, hyperferremia, hyperglycemia, hypomagnesemia, and hypokalemia. Abdominocentesis was compatible with low-protein transudate. Due to the progression and duration of clinical signs, the owner elected euthanasia...
April 20, 2024: Journal of Veterinary Diagnostic Investigation
https://read.qxmd.com/read/38640733/moesin-deficiency-leads-to-lupus-like-nephritis-with-accumulation-of-cxcl13-producing-patrolling-monocytes
#5
JOURNAL ARTICLE
Satoko Ichioka, Hiroki Satooka, Yoshihiro Maruo, Takako Hirata
Moesin is a member of the ezrin-radixin-moesin (ERM) family of proteins that link plasma membrane proteins to the cortical cytoskeleton and thus regulate diverse cellular processes. Mutations in the human moesin gene cause a primary immunodeficiency called X-linked moesin-associated immunodeficiency (X-MAID), which may be complicated by an autoimmune phenotype with kidney involvement. We previously reported that moesin-deficient mice exhibit lymphopenia similar to that of X-MAID and develop a lupus-like autoimmune phenotype with age...
April 16, 2024: Biochemical and Biophysical Research Communications
https://read.qxmd.com/read/38633118/early-car-cd4-t-lymphocytes-recovery-following-car-t-cell-infusion-a-worse-outcome-in-diffuse-large-b-cell-lymphoma
#6
JOURNAL ARTICLE
Massimiliano Gambella, Simona Carlomagno, Rosa Mangerini, Nicoletta Colombo, Alessia Parodi, Chiara Ghiggi, Livia Giannoni, Elisa Coviello, Chiara Setti, Silvia Luchetti, Alberto Serio, Antonella Laudisi, Monica Passannante, Alessandra Bo, Elisabetta Tedone, Simona Sivori, Emanuele Angelucci, Anna Maria Raiola
CAR- CD4+ T cell lymphopenia is an emerging issue following CAR-T cell therapy. We analyzed the determinants of CD4+ T cell recovery and a possible association with survival in 31 consecutive patients treated with commercial CAR-T for diffuse large B-cell (DLBCL) or mantle cell lymphoma. Circulating immune subpopulations were characterized through multiparametric-flow cytometry. Six-month cumulative incidence of CAR- CD4+ T cell recovery (≥200 cells/μL) was 0.43 (95% confidence interval [CI]: 0...
April 2024: EJHaem
https://read.qxmd.com/read/38630321/clinical-impact-of-transient-lymphopenia
#7
JOURNAL ARTICLE
Luigi Petramala, Cinzia Milito, Francesca Sarlo, Adriana Servello, Francesco Circosta, Luca Marino, Germano Sardella, Piero Trapani, Giulio D'aguanno, Antonino Cimo', Gioacchino Galardo, Claudio Letizia
Transient or persistent immunosuppression is a known risk factor for morbidity and mortality in critically ill patients. Aim of the present study is to evaluate the lymphopenia in patients admitted to the Emergency Unit of AOU Policlinico Umberto I, to investigate its prevalence at admission and the persistence during hospitalization until discharge. Possible correlations were evaluated between lymphopenia, diagnosis of admission, comorbidities and chronic treatments. In this study, 240 patients (142 men; 98 female; mean age 75...
April 17, 2024: Clinical and Experimental Medicine
https://read.qxmd.com/read/38623881/long-term-outcomes-of-two-dose-alemtuzumab-induction-in-pediatric-kidney-transplantation
#8
MULTICENTER STUDY
Rachel M Engen, Sharon M Bartosh
BACKGROUND: Alemtuzumab is a lymphocyte depleting agent used for induction in kidney transplant, but long-term information on its use in pediatric recipients remains sparse. METHODS: We performed a single-center retrospective cohort study of 57 pediatric kidney transplant recipients receiving alemtuzumab 20 mg/m2 /dose ×2 doses for induction immunosuppression. All patients underwent surveillance biopsies, and 91.3% underwent steroid withdrawal by day 4 post-transplant...
May 2024: Pediatric Transplantation
https://read.qxmd.com/read/38617523/predictors-of-mortality-in-hospitalized-african-american-covid-19-patients-with-cancer
#9
JOURNAL ARTICLE
Suryanarayana Reddy Challa, Gholamreza Oskrochi, Gagan Paul Singh, Lakshmi G Chirumamilla, Nader Shayegh, Vaisakh K Nair, Megan Littleton, Danae T Byer, Nicole A Morrison, Brittany L Grossi, Barclay Ashanna, Shahnoza Dusmatova, Trae Thompson, Dideolu O Dawodu, Hassan Brim, Hassan Ashktorab
BACKGROUND: Coronavirus disease 2019 (COVID-19) manifest differently depending on patients' background and pre-existing conditions. It remains unclear how African Americans with cancer have been affected in comparison to those without. In this study, we aim to identify demographic, clinical, and laboratory markers associated with mortality in COVID-19 patients with cancer. METHODS: We reviewed all COVID-19 hospitalized patients' records from Dec. 2019 to Oct. 2021 at Howard University Hospital...
March 31, 2024: Translational Cancer Research
https://read.qxmd.com/read/38610602/personalized-assessment-of-mortality-risk-and-hospital-stay-duration-in-hospitalized-patients-with-covid-19-treated-with-remdesivir-a-machine-learning-approach
#10
JOURNAL ARTICLE
Antonio Ramón, Andrés Bas, Santiago Herrero, Pilar Blasco, Miguel Suárez, Jorge Mateo
Background: Despite advancements in vaccination, early treatments, and understanding of SARS-CoV-2, its impact remains significant worldwide. Many patients require intensive care due to severe COVID-19. Remdesivir, a key treatment option among viral RNA polymerase inhibitors, lacks comprehensive studies on factors associated with its effectiveness. Methods: We conducted a retrospective study in 2022, analyzing data from 252 hospitalized COVID-19 patients treated with remdesivir. Six machine learning algorithms were compared to predict factors influencing remdesivir's clinical benefits regarding mortality and hospital stay...
March 22, 2024: Journal of Clinical Medicine
https://read.qxmd.com/read/38605496/new-onset-lymphopenia-in-patients-with-relapsing-multiple-sclerosis-switching-from-long-standing-dimethyl-fumarate-treatment-to-diroximel-fumarate-a-case-series
#11
JOURNAL ARTICLE
Megan Schneider, John Kramer, Aimee Banks, Harold Moses
Lymphopenia is a known adverse effect in patients with relapsing multiple sclerosis (RMS) treated with fumaric acids. We present a case series of four patients diagnosed with RMS with prolonged lymphocyte stability on dimethyl fumarate for over 1 year who developed significant lymphopenia after transitioning to diroximel fumarate. This case series highlights the need for further research to elucidate the risk of lymphopenia in patients switching between fumaric acids.
April 11, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38605492/drug-induced-lymphopenia-are-all-fumarates-the-same
#12
JOURNAL ARTICLE
Ralf Gold, Jeremias Motte
No abstract text is available yet for this article.
April 11, 2024: Multiple Sclerosis: Clinical and Laboratory Research
https://read.qxmd.com/read/38605470/lessons-from-prospective-longitudinal-follow-up-of-a-french-apeced-cohort
#13
JOURNAL ARTICLE
Linda Humbert, Emmanuelle Proust-Lemoine, Sylvain Dubucquoi, Elisabeth Helen Kemp, Pascale Saugier-Veber, Nicole Fabien, Isabelle Raymond-Top, Catherine Cardot-Bauters, Jean-Claude Carel, Maryse Cartigny, Olivier Chabre, Philippe Chanson, Brigitte Delemer, Christine Do Cao, Laurence Guignat, Jean Emmanuel Kahn, Veronique Kerlan, Herve Lefebvre, Agnès Linglart, Roberto Mallone, Rachel Reynaud, Boualem Sendid, Pierre-François Souchon, Philippe Touraine, Jean-Louis Wémeau, Marie-Christine Vantyghem
BACKGROUND: APECED syndrome is a rare disease caused by biallelic mutations of the AIRE gene, usually presenting with the triad "hypoparathyroidism-adrenal failure-chronic mucocutaneous candidiasis (CMC)" and non-endocrine manifestations. The aim of this study was to determine the molecular profile of the AIRE gene, the prevalence of rare manifestations and to characterize immunological disturbances in a French cohort. PATIENTS AND METHODS: A national, multicenter prospective observational study to collect genetic, clinical, biological and immunological data (NCT03751683)...
April 12, 2024: Journal of Clinical Endocrinology and Metabolism
https://read.qxmd.com/read/38596857/real-world-study-on-the-use-of-pegylated-interferon-alpha-2a-for-treatment-of-mycosis-fungoides-s%C3%A3-zary-syndrome-using-time-to-next-treatment-as-a-measure-of-clinical-benefit-an-eortc-cltg-study
#14
JOURNAL ARTICLE
Keila Mitsunaga, Martine Bagot, Caroline Ram-Wolff, Emmanuella Guenova, Christina von Gugelberg, Emmilia Hodak, Iris Amitay-Laish, Evangelia Papadavid, Constanze Jonak, Stefanie Porkert, Julia Scarisbrick, Rona Applewaite, Marie Beylot-Barry, Jan Nicolay, Pietro Quaglino, José Antonio Sanches, Jade Cury-Martins, David Lora-Pablos, Pablo Ortiz
INTRODUCTION: Mycosis fungoides (MF) and Sézary syndrome (SS) are chronic malignant diseases that typically necessitate diverse strategies to achieve remission. Systemic interferon alpha (IFN-α, subtypes 2a and 2b) has been used for MF/SS since 1984, however its production was recently stopped and so the recombinant pegylated (PEG) form of IFN α-2a remains as single IFN alternative treatment, even though not approved for MF/SS. OBJECTIVE: To assess effectiveness and safety of PEG IFN α-2a in monotherapy and in combination with other treatments using time to next treatment (TTNT) as a measure of clinical therapeutic benefit in real world setting...
April 10, 2024: British Journal of Dermatology
https://read.qxmd.com/read/38596441/systemic-juvenile-idiopathic-arthritis-associated-lung-disease-a-retrospective-cohort-study
#15
JOURNAL ARTICLE
Konstantin E Belozerov, Natalia M Solomatina, Eugenia A Isupova, Alla A Kuznetsova, Mikhail M Kostik
BACKGROUND: Lung damage in systemic juvenile arthritis (sJIA) is one of the contemporary topics in pediatric rheumatology. Several previous studies showed the severe course and fatal outcomes in some patients. The information about interstitial lung disease (ILD) in the sJIA is scarce and limited to a total of 100 cases. AIM: To describe the features of sJIA patients with ILD in detail. METHODS: In the present retrospective cohort study, information about 5 patients less than 18-years-old with sJIA and ILD were included...
March 9, 2024: World Journal of Clinical Pediatrics
https://read.qxmd.com/read/38593817/lymphodose-a-lymphocyte-dose-estimation-framework-application-to-brain-radiotherapy
#16
JOURNAL ARTICLE
François de Kermenguy, Nathan Benzazon, Pauline Maury, Rémi Vauclin, Meissane M'hamdi, Vjona Cifliku, Elaine Limkin, Ibrahima Diallo, Daphné Morel, Candice Milewski, Céline Clémenson, Michele Mondini, Eric Deutsch, Charlotte Robert
Severe radiation-induced lymphopenia occurs in 40% of patients treated for primary brain tumors and is an independent risk factor of poor survival outcomes. We developed an in-silico framework that estimates the radiation doses received by lymphocytes during VMAT brain irradiation. 
Approach: We implemented a simulation consisting of two interconnected compartmental models describing the slow recirculation of lymphocytes between lymphoid organs (M_1) and the bloodstream (M_2). We used dosimetry data from 33 patients treated with chemo-radiation for glioblastoma to compare three cases of the model, corresponding to different physical and biological scenarios: H1) lymphocytes circulation only in the bloodstream i...
April 9, 2024: Physics in Medicine and Biology
https://read.qxmd.com/read/38593221/long-term-treatment-with-selective-pi3k%C3%AE-inhibitor-leniolisib-in-adults-with-activated-pi3k%C3%AE-syndrome
#17
JOURNAL ARTICLE
V Koneti Rao, Elaine M Kulm, Jennifer K Grossman, David K Buchbinder, Hey Chong, Jason Bradt, Sharon Webster, Anna Šedivá, Virgil A Dalm, Gulbu Uzel
Activated phosphoinositide 3-kinase delta syndrome (APDS) is an inborn error of immunity that manifests as immune deficiency and dysregulation; symptoms include frequent infections and lymphoproliferation. In our dose-finding and phase 3 placebo-controlled trials, treatment with the selective PI3Kδ inhibitor leniolisib reduced lymphoproliferation and normalized lymphocyte subsets. Here, we present 6 years of follow-up from the 6 adult patients in the original dose-finding trial receiving leniolisib. We used data from the ongoing open-label extension study, which was supplemented at later time points by investigators, including health-related quality of life assessed through a clinician-reported questionnaire...
April 9, 2024: Blood Advances
https://read.qxmd.com/read/38592364/blood-whispers-exploring-hematologic-indicators-for-diagnosing-and-predicting-severity-of-vogt-koyanagi-harada-syndrome
#18
JOURNAL ARTICLE
Berru Yargi-Ozkocak, Cigdem Altan, Burcu Kemer-Atik, Berna Basarir, Muhittin Taskapili
PURPOSE: To investigate the association of clinical findings and indocyanine green angiography (ICGA) score with inflammatory markers derived from complete blood count (CBC) parameters in patients with Vogt-Koyanagi-Harada (VKH) to determine the diagnostic and predictive role. METHODS: Demographic characteristics, presenting complaints, ocular findings, optical coherence tomography findings, ICGA scores and best corrected visual acuity were recorded in treatment-naive VKH patients at presentation...
April 9, 2024: Ocular Immunology and Inflammation
https://read.qxmd.com/read/38587749/narrative-review-on-the-use-of-cladribine-tablets-as-exit-therapy-for-stable-elderly-patients-with-multiple-sclerosis
#19
REVIEW
Jerome de Seze, Dominique Dive, Xavier Ayrignac, Giovanni Castelnovo, Marianne Payet, Amel Rayah, Claudio Gobbi, Patrick Vermersch, Chiara Zecca
The number of ageing people with relapsing multiple sclerosis (RMS) is increasing. The efficacy of disease-modifying therapies (DMTs) for RMS declines with age. Also, older persons with MS may be more susceptible to infections, hospitalisations and malignancy. Aging people with MS have higher rates of comorbidities versus aged-matched controls, increasing the individual risk of disability. We review the therapeutic properties of cladribine tablets (CladT) in ageing people with RMS, with regard to their utility for allowing these individuals to cease continuous administration of a DMT (i...
April 8, 2024: Neurology and Therapy
https://read.qxmd.com/read/38587703/novel-synonymous-variant-in-il7r-causes-preferential-expression-of-the-soluble-isoform
#20
JOURNAL ARTICLE
Rafah Mackeh, Yasmin El Bsat, Asha Elmi, Hani Bibawi, Mohammed Yousuf Karim, Amel Hassan, Bernice Lo
PURPOSE: The interleukin-7 receptor (IL-7R) is primarily expressed on lymphoid cells and plays a crucial role in the development, proliferation, and survival of T cells. Autosomal recessive mutations that disrupt IL-7Rα chain expression give rise to a severe combined immunodeficiency (SCID), which is characterized by lymphopenia and a T- B+ NK+ phenotype. The objective here was to diagnose two siblings displaying the T- B+ NK+ SCID phenotype as initial clinical genetic testing did not detect any variants in known SCID genes...
April 8, 2024: Journal of Clinical Immunology
keyword
keyword
86089
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.